Selected article for: "age distribution and infection proportion"
Author: Julien Riou; Anthony Hauser; Michel J Counotte; Christian L Althaus
Title: Adjusted age-specific case fatality ratio during the COVID-19 epidemic in Hubei, China, January and February 2020
  • Document date: 2020_3_6
    • ID: mrsya6wz_20
    Snippet: Among infected individuals with symptoms, which is more relevant to the clinical situation, adjusted mortality is estimated at 3.6% (95%CrI: 3.1-4.1). Under 20 years of age, mortality among symptomatics is estimated below 1 in 1,000 and rises to between 3 to 8 per 1,000 symptomatic infections for individuals aged 20 to 49 years. Mortality among symptomatics is estimated to 2.5% (95%CrI: 1.9-3.1) among individuals aged 50-59, 8.0% (95%CrI: 6.6-9.5.....
    Document: Among infected individuals with symptoms, which is more relevant to the clinical situation, adjusted mortality is estimated at 3.6% (95%CrI: 3.1-4.1). Under 20 years of age, mortality among symptomatics is estimated below 1 in 1,000 and rises to between 3 to 8 per 1,000 symptomatic infections for individuals aged 20 to 49 years. Mortality among symptomatics is estimated to 2.5% (95%CrI: 1.9-3.1) among individuals aged 50-59, 8.0% (95%CrI: 6.6-9.5) among individuals aged 60-69, 19 .2% (95%CrI: 15.8-22.9) among individuals aged 70-79 and reaches 39.0% (95%CrI: 31.1-48.9) among individuals aged 80 and more. The estimated prevalence of the four comorbidities is shown in Figure 3C . Compared with the expected prevalence given the age-distribution of deaths associated with SARS-CoV-2 infection, we observe a higher proportion of patients with diabetes and a lower proportion with chronic respiratory disease or hypertension among Covid-19 deaths in Hubei

    Search related documents:
    Co phrase search for related documents
    • adjusted mortality and estimate prevalence: 1
    • adjusted mortality and high proportion: 1, 2, 3
    • adjusted mortality and hypertension chronic respiratory disease: 1, 2
    • adjusted mortality and respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adjusted mortality and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chronic respiratory disease and estimate prevalence: 1, 2
    • chronic respiratory disease and high proportion: 1, 2, 3, 4
    • chronic respiratory disease and hypertension chronic respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chronic respiratory disease and infected individual: 1
    • chronic respiratory disease and respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chronic respiratory disease and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical situation and infected individual: 1, 2, 3
    • clinical situation and respiratory disease: 1, 2, 3, 4
    • clinical situation and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • diabetes patient and expect prevalence: 1
    • diabetes patient and high proportion: 1
    • diabetes patient and respiratory disease: 1, 2, 3, 4, 5, 6, 7
    • diabetes patient and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • estimate prevalence and high proportion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10